Search Login Register

Unverricht-Lundborg Syndrome (Disease, Unverricht) Summary

Description: An autosomal recessive condition characterized by recurrent myoclonic and generalized seizures, ATAXIA, slowly progressive intellectual deterioration, dysarthria, and intention tremor. Myoclonic seizures are severe and continuous, and tend to be triggered by movement, stress, and sensory stimuli. The age of onset is between 8 and 13 years, and the condition is relatively frequent in the Baltic region, especially Finland. (From Menkes, Textbook of Child Neurology, 5th ed, pp109-110)

Also Known As: Disease, Unverricht; Baltic Myoclonus Epilepsy; Unverricht Disease; Baltic Myoclonus Epilepsies; Diseases, Unverricht Show All >>

Networked: 7 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Unverricht-Lundborg Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cystatin B : 2 results : IBA
  2. Phenytoin (Dilantin) : 2 results : FDA 9 Generic
  3. Cystatin C : 1 result : IBA
  4. Homocystine : 1 result : IBA
  5. Adrenocorticotropic Hormone (ACTH) : 1 result : FDA 7
  6. Pyruvate dehydrogenase deficiency : 1 result : IBA
  7. Lennox-Gastaut type Epileptic encephalopathy : 1 result : IBA
  8. pentigide (HEPP) : 1 result : IBA
  9. 5,6,7,8-tetrahydrofolic acid (tetrahydrofolate) : 1 result : IBA

Diseases Related to Unverricht-Lundborg Syndrome

  1. Multiple Acyl Coenzyme A Dehydrogenase Deficiency
  2. Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
  3. Myoclonus (Nocturnal Myoclonus)
  4. Metachromatic Leukodystrophy (Sulfatide Lipidosis)
  5. Leigh Disease (Leigh's Disease)
Show All >>

Key Therapies for Unverricht-Lundborg Syndrome

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.